All In MedTech

Device Trial Radar · NCT05016674

Assessment of Cellular and Tissue Characteristics in Lipoaspirates Stirred by VorFat

Assessment of Cellular and Tissue Characteristics in Lipoaspirates Harvested With the LipoLife System and Stirred by VorFat

Last checked: Nov 20, 2026Latest source record: Sep 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Jul 21, 2021

Primary completion

Feb 1, 2023

Study completion May 1, 2023

Sponsor

Lead sponsor
Alma LasersNot on our public-company list
Sponsor type
Industry
First posted
Aug 23, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Single-center, prospective, open-label study. The study aims to assess the structure and viability of fat collected during the LipoLife liposuction procedure

Conditions

  • Laser Assisted Liposuction

Interventions

  • LipoLife systemDevice

    Abdominal Laser-Assisted Liposuction

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Average adipose cell cluster sizeTime frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • William Jason Martin, MD

    Denver, Colorado

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.